Jove
Visualize
Contact Us

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing human rabies prevention in Brazil through spatial prioritization and a One Health approach.

Scientific reports·2026
Same author

Accelerating Disease Model Parameter Extraction: An LLM-Based Ranking Approach to Select Initial Studies For Literature Review Automation.

Machine learning and knowledge extraction·2026
Same author

The Effect of Climate Change on Emergence and Evolution of Zoonotic Diseases in Asia.

Zoonoses and public health·2025
Same author

The association between rainfall and human leptospirosis in Aotearoa New Zealand.

Epidemiology and infection·2025
Same author

Probability of freedom from foot-and-mouth disease virus serotype Asia 1 in Southeast Asia, China and Mongolia.

Preventive veterinary medicine·2025
Same author

Modelling the spread of Salmonid Rickettsial Septicaemia and assessing regional control strategies for saltwater salmon farms in Aysén, Chile.

Preventive veterinary medicine·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 10, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

[Anti-tuberculosis chemotherapy].

Masako Wada1

  • 1Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose-shi, Tokyo. wada@jata.or.jp

Kekkaku : [Tuberculosis]
|November 21, 2007
PubMed
Summary

Tuberculosis treatment has evolved from lengthy multi-drug therapies to effective short-course regimens. Implementing a practical Directly Observed Treatment, Short-course (DOTS) system with pharmacists is key to preventing multidrug-resistant tuberculosis.

Area of Science:

  • Medical Microbiology
  • Pharmacology
  • Public Health

Context:

  • Tuberculosis (TB) treatment has transformed significantly since the discovery of streptomycin in 1943.
  • Early multi-drug therapies required over a year of treatment, leading to challenges with patient compliance.
  • The introduction of rifampicin and pyrazinamide enabled a revolutionary six-month short-course chemotherapy regimen, becoming the global standard.

Purpose:

  • To review the historical evolution of tuberculosis chemotherapy.
  • To highlight the challenges of patient non-compliance in ambulatory treatment settings.
  • To introduce a novel Directly Observed Treatment, Short-course (DOTS) system utilizing city pharmacists in Japan.

Summary:

  • The development of anti-tuberculosis drugs has progressed from streptomycin to highly effective short-course chemotherapy.

Related Experiment Videos

Last Updated: Jul 10, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

  • Patient non-compliance remains a significant obstacle, leading to treatment failures and the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis.
  • A pilot DOTS program using pharmacists as observers in Japan showed promise for improving treatment adherence and preventing drug resistance.
  • Impact:

    • Successful implementation of DOTS programs can prevent the global spread of MDR and XDR-TB.
    • The proposed pharmacist-led DOTS system offers a practical and acceptable model for ambulatory tuberculosis treatment in Japan.
    • Further development of new anti-tuberculosis drugs is crucial for even shorter and more effective treatment durations.